| Horizon Health And Wellness, Inc. | |
|
625 N Plaza Dr Apache Junction AZ 85120-5501 | |
| (480) 983-0065 | |
| (480) 671-4541 |
| Full Name | Horizon Health And Wellness, Inc. |
|---|---|
| Speciality | General Practice |
| Location | 625 N Plaza Dr, Apache Junction, Arizona |
| Authorized Official Name and Position | Billie Holliday (CHIEF OPERATING OFFICER) |
| Authorized Official Contact | 4809830065 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Horizon Health And Wellness, Inc. 625 N. Plaza Drive Apache Junction AZ 85120-5501 Ph: (480) 983-0065 | Horizon Health And Wellness, Inc. 625 N Plaza Dr Apache Junction AZ 85120-5501 Ph: (480) 983-0065 |
| NPI Number | 1659308989 |
|---|---|
| Provider Enumeration Date | 06/26/2006 |
| Last Update Date | 03/23/2023 |
| Certification Date | 03/23/2023 |
| Medicare PECOS PAC ID | 6406759711 |
|---|---|
| Medicare Enrollment ID | O20040202000450 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659308989 | NPI | - | NPPES |
| 057340 | Medicaid | AZ |
| Provider Name | Louis G Trunzo |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1922067545 PECOS PAC ID: 6709783343 Enrollment ID: I20040128001082 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Christian J Moher |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1497731582 PECOS PAC ID: 2961397161 Enrollment ID: I20040217000728 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Muhammad A Haleem |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356439012 PECOS PAC ID: 0345239158 Enrollment ID: I20040507000716 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Richelle Ramirez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396817862 PECOS PAC ID: 2062451750 Enrollment ID: I20050502001197 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Dmitry V Listengarten |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1669433173 PECOS PAC ID: 4486680931 Enrollment ID: I20050715000218 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Robert W Young |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1093867491 PECOS PAC ID: 6002844487 Enrollment ID: I20050727000739 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Antonio L Carr |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1801818349 PECOS PAC ID: 3476577289 Enrollment ID: I20060119000676 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Svetlana V Zak |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386831832 PECOS PAC ID: 3375610926 Enrollment ID: I20080923000604 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Kathryn L Mcneil |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902859903 PECOS PAC ID: 7618043043 Enrollment ID: I20081006000354 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Lori A Park |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1053561431 PECOS PAC ID: 2365595568 Enrollment ID: I20090805000827 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Joyce C Morton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831322023 PECOS PAC ID: 2769538339 Enrollment ID: I20090923000387 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Sabrina Marmont |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437395316 PECOS PAC ID: 1254456049 Enrollment ID: I20100916001104 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Kelly A Haines |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538437611 PECOS PAC ID: 0143483065 Enrollment ID: I20120511000454 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Renee H Kania |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184940652 PECOS PAC ID: 6204088123 Enrollment ID: I20121128000558 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Joycelyn Connet |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225377898 PECOS PAC ID: 3870732712 Enrollment ID: I20130625000533 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Maurice D Lee |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1861719825 PECOS PAC ID: 3870736374 Enrollment ID: I20130903000222 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Paige K Crozier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467732990 PECOS PAC ID: 6204076177 Enrollment ID: I20140624000513 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Maryam H Lateef |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477533610 PECOS PAC ID: 3577475888 Enrollment ID: I20141023000369 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Lynn C Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124318159 PECOS PAC ID: 3577885441 Enrollment ID: I20141203001847 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Steji Koshy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982087946 PECOS PAC ID: 5890001200 Enrollment ID: I20150831002750 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Angela Marie Webb |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639553704 PECOS PAC ID: 3476860859 Enrollment ID: I20150917000372 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Karen Lutostanski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447631940 PECOS PAC ID: 8628386471 Enrollment ID: I20150929001349 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Sharon A Stokes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144376070 PECOS PAC ID: 5991014581 Enrollment ID: I20151021003327 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Lindsay D Mason |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467859256 PECOS PAC ID: 4587974753 Enrollment ID: I20151030002053 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Violet M Baruti |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508289919 PECOS PAC ID: 4880816669 Enrollment ID: I20160308001924 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Brandi D Morgan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699085126 PECOS PAC ID: 5395967285 Enrollment ID: I20160422002116 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Sarah Manco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396907598 PECOS PAC ID: 3678736238 Enrollment ID: I20160429000909 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Susan K Jostes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356776819 PECOS PAC ID: 5799084109 Enrollment ID: I20160505001053 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Kathleen M Casey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457385502 PECOS PAC ID: 5991094823 Enrollment ID: I20160517001592 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Sandra Np Walker-lee |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912338633 PECOS PAC ID: 0446483879 Enrollment ID: I20160616001167 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Jonquil Michael |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376940957 PECOS PAC ID: 2062711237 Enrollment ID: I20160725001523 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Stephanie Plummer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598786469 PECOS PAC ID: 0143514828 Enrollment ID: I20160803000387 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Jackie Ollis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750735163 PECOS PAC ID: 8628362639 Enrollment ID: I20160812001235 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Molly E Haak |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1043761067 PECOS PAC ID: 8426336025 Enrollment ID: I20161102001989 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Kerby B Mcdonald |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053662007 PECOS PAC ID: 4486805587 Enrollment ID: I20170105001915 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Joann Sciacca |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255444147 PECOS PAC ID: 0042591869 Enrollment ID: I20170110000102 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Kelleen Stiles |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437468840 PECOS PAC ID: 9638453160 Enrollment ID: I20170301002060 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Torry Zupke |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558606467 PECOS PAC ID: 5395990113 Enrollment ID: I20170317000748 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Amy Melissa Porter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528515814 PECOS PAC ID: 2961779368 Enrollment ID: I20170606000239 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Gina Pitocchelli |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366886426 PECOS PAC ID: 3173753886 Enrollment ID: I20170615002618 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Jocelyn Verdugo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1861804270 PECOS PAC ID: 4587932066 Enrollment ID: I20170626001513 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Michele Rickman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083046957 PECOS PAC ID: 0244453512 Enrollment ID: I20170627001774 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Robin M Shepherd |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245760420 PECOS PAC ID: 9739459025 Enrollment ID: I20170719001821 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Sarah M Sherman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1154614485 PECOS PAC ID: 1153691365 Enrollment ID: I20170720002860 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Joan Vojtkofsky |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689912958 PECOS PAC ID: 9234376427 Enrollment ID: I20170802001391 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Alexander Labrador |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528516788 PECOS PAC ID: 7810269834 Enrollment ID: I20170824003033 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Dee Guy Lewis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902839848 PECOS PAC ID: 6800856089 Enrollment ID: I20170829004187 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Barbara A Browder |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740702901 PECOS PAC ID: 1254604952 Enrollment ID: I20170831000686 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Marcus L Robinson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740736537 PECOS PAC ID: 0547540247 Enrollment ID: I20170905001050 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Dana Eason |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710190715 PECOS PAC ID: 7315267580 Enrollment ID: I20170921003121 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Deanna J Kristofic |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013207489 PECOS PAC ID: 9133396716 Enrollment ID: I20171002003783 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | James A Benn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790100287 PECOS PAC ID: 5799900015 Enrollment ID: I20171109001750 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Aileen Wright |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669790457 PECOS PAC ID: 8820237233 Enrollment ID: I20171213002839 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Jetta Derasin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720336910 PECOS PAC ID: 5991953911 Enrollment ID: I20180214001235 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Brett L Leifson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003338518 PECOS PAC ID: 0042572752 Enrollment ID: I20180316001218 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Sharon R Gardner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205999703 PECOS PAC ID: 8729125224 Enrollment ID: I20180427002013 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Carolyne Adero |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013415843 PECOS PAC ID: 3072878198 Enrollment ID: I20180521000542 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Kyle Bart Dewey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477046902 PECOS PAC ID: 2567719982 Enrollment ID: I20180717001381 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Lovely Omoregbe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467875724 PECOS PAC ID: 9739310483 Enrollment ID: I20180724004083 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Camay S Rooney |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255820346 PECOS PAC ID: 6305194747 Enrollment ID: I20180801002906 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Sarah Elizabeth Mckenna |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1356729594 PECOS PAC ID: 1658629944 Enrollment ID: I20180802001349 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Munachiso Iheonunekwu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922505908 PECOS PAC ID: 3274882352 Enrollment ID: I20180822003213 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Sandra B Fedie |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215441035 PECOS PAC ID: 5193084531 Enrollment ID: I20180918004206 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Arthur Y Chou |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1982788899 PECOS PAC ID: 7214943075 Enrollment ID: I20181127000927 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Marla J Van Tassell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801266572 PECOS PAC ID: 1355644964 Enrollment ID: I20181217001672 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Melissa Fenrich |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1851867170 PECOS PAC ID: 3375881683 Enrollment ID: I20190212002272 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Kathleen A Mccarvell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154500981 PECOS PAC ID: 5193898419 Enrollment ID: I20190415000674 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Allison C Scott |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1265998561 PECOS PAC ID: 3375877103 Enrollment ID: I20190627000881 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Nichole B Roller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780004473 PECOS PAC ID: 3173741956 Enrollment ID: I20190705001221 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Charlene Scarlett Diaz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518524982 PECOS PAC ID: 9436484292 Enrollment ID: I20190716002175 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Karisa Harpe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629304050 PECOS PAC ID: 2567501463 Enrollment ID: I20190726000190 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Chidozie Eze |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174003909 PECOS PAC ID: 7810228459 Enrollment ID: I20191011000966 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Christian M Azode |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306492046 PECOS PAC ID: 6103252580 Enrollment ID: I20200203001686 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Julie Marie Shute |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023388279 PECOS PAC ID: 0749619948 Enrollment ID: I20200409002825 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Janelle S Rudnick |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851766646 PECOS PAC ID: 2264734888 Enrollment ID: I20200612001288 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Gayle Cecilia Bachelier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861019416 PECOS PAC ID: 9638594997 Enrollment ID: I20200803002544 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Danielle Fedor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487263570 PECOS PAC ID: 3678999695 Enrollment ID: I20200820001362 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Daed Lizbeth Ayala Penaloza |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1093281883 PECOS PAC ID: 5597181545 Enrollment ID: I20200820002548 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Dawn M Murphy |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1669612842 PECOS PAC ID: 2567733942 Enrollment ID: I20201013002553 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Mitchell Garrett Brown |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407456668 PECOS PAC ID: 5496167579 Enrollment ID: I20201214002734 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Lashaun Perry |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649880592 PECOS PAC ID: 7618386897 Enrollment ID: I20210429003022 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Joan Ili |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194946012 PECOS PAC ID: 0244639565 Enrollment ID: I20210518002975 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Martin Bazi |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1265582290 PECOS PAC ID: 3173697034 Enrollment ID: I20210603002508 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Starr Rapeta |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689116501 PECOS PAC ID: 3779983945 Enrollment ID: I20210609001058 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Breenecia Scott |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306324769 PECOS PAC ID: 9436559614 Enrollment ID: I20210609001378 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Tina Grinsteiner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104403708 PECOS PAC ID: 5395146609 Enrollment ID: I20210624000460 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Saleh Bahati |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669143145 PECOS PAC ID: 9133527427 Enrollment ID: I20211018002941 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Esther Ansah Nuamah |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902430853 PECOS PAC ID: 2769871508 Enrollment ID: I20211116002010 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Mitsy Dawn Morton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639811771 PECOS PAC ID: 5991183378 Enrollment ID: I20220526002001 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Gina Pollina |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396216289 PECOS PAC ID: 7618308248 Enrollment ID: I20220909002578 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Jacqueline P. Parkes |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1225753346 PECOS PAC ID: 5597131094 Enrollment ID: I20221025002923 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Macie Lanae Myers Aufiero |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1346605508 PECOS PAC ID: 2466807490 Enrollment ID: I20231011003697 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Janet Callon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033296561 PECOS PAC ID: 8820018757 Enrollment ID: I20231218002030 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Kai M Kline |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1831762244 PECOS PAC ID: 1052762697 Enrollment ID: I20240109001029 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Julie Wilder |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1124491790 PECOS PAC ID: 7719339456 Enrollment ID: I20240118004109 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Lynda M King |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1801297338 PECOS PAC ID: 9335592971 Enrollment ID: I20240130002484 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Trenton L Tinsley |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1225510274 PECOS PAC ID: 1052755006 Enrollment ID: I20240216003805 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
| Provider Name | Cassidy Lorraine Ducray |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144929084 PECOS PAC ID: 5597101170 Enrollment ID: I20240306002691 |
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
News Archive
Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.
The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.
Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.
Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.
› Verified 8 days ago
San Tan Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 288 N Ironwood Dr Ste 101, Apache Junction, AZ 85220 Phone: 480-982-2356 Fax: 480-982-2449 | |
Oak Street Health Physicians Group Of Arizona Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 183 W Apache Trl, Apache Junction, AZ 85120 Phone: 480-618-0945 Fax: 602-671-6859 | |
Apache Junction Unified School District #43 Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1575 W Southern Ave, Suite 6, Apache Junction, AZ 85220 Phone: 480-982-1110 Fax: 480-983-6497 | |
Aj Adult With Serious Mental Illness Program Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 11518 E Apache Trl, #129, Apache Junction, AZ 85120 Phone: 480-784-1514 Fax: 480-967-3528 | |
By Your Side Behavioral Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1226 W 13th Ave, Apache Junction, AZ 85120 Phone: 480-388-4906 | |
Apache Junction Unified School District #43 Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1575 W Southern Ave, Suite 6, Apache Junction, AZ 85220 Phone: 480-982-1110 Fax: 480-983-6497 | |
Apache Health, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 S Idaho Rd, Apache Junction, AZ 85119 Phone: 775-354-9789 |